Journal article
Optimal Strategies for Reporting Pain in Clinical Trials and Systematic Reviews: Recommendations from an OMERACT 12 Workshop.
Abstract
OBJECTIVE: Pain is a patient-important outcome, but current reporting in randomized controlled trials and systematic reviews is often suboptimal, impeding clinical interpretation and decision making.
METHODS: A working group at the 2014 Outcome Measures in Rheumatology (OMERACT 12) was convened to provide guidance for reporting treatment effects regarding pain for individual studies and systematic reviews.
Authors
Busse JW; Bartlett SJ; Dougados M; Johnston BC; Guyatt GH; Kirwan JR; Kwoh K; Maxwell LJ; Moore A; Singh JA
Journal
The Journal of Rheumatology, Vol. 42, No. 10, pp. 1962–1970
Publisher
The Journal of Rheumatology
Publication Date
October 2015
DOI
10.3899/jrheum.141440
ISSN
0315-162X